135 related articles for article (PubMed ID: 6331302)
1. Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections.
Lentino JR; Stachowski M; Strikas R; Parrillo P
Antimicrob Agents Chemother; 1984 Jun; 25(6):778-80. PubMed ID: 6331302
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of cefotiam (CGP/14221) versus cephalothin in the treatment of urinary tract infections.
Tselentis J; Cordossis T; Eliopoulos G
Pharmatherapeutica; 1983; 3(6):382-7. PubMed ID: 6312460
[TBL] [Abstract][Full Text] [Related]
3. [Microbiologic and clinical significance of cefotiam].
Tauchnitz C; Ezold R; Bauer I; Berger HD; Buhl C; Goedecke A; Morawietz I
Z Gesamte Inn Med; 1985 Mar; 40(5):143-8. PubMed ID: 3857792
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies of cefotiam in the field of otorhinolaryngology].
Takeda K; Yoshida M; Ishida T
Jpn J Antibiot; 1983 Oct; 36(10):2715-20. PubMed ID: 6325741
[TBL] [Abstract][Full Text] [Related]
5. [Fundamental and clinical studies of cefotiam in the field of oral surgery].
Yamamoto T; Namba R; Taguchi M; Tsutou H; Minami Y; Ueda K; Tsushima T; Morihana T; Nagata K; Nakao K; Shimada K
Jpn J Antibiot; 1982 Sep; 35(9):2219-33. PubMed ID: 6292540
[TBL] [Abstract][Full Text] [Related]
6. [Clinical studies of cefotiam in otorhinolaryngologic infections].
Satake K; Tanino T; Naito T; Osafune H; Komatsuzaki A
Jpn J Antibiot; 1983 Oct; 36(10):2683-7. PubMed ID: 6325737
[TBL] [Abstract][Full Text] [Related]
7. [Clinical experience with cefotiam in the otorhinolaryngologic field].
Sugiyama M; Goto K; Ohashi Y; Nakai Y
Jpn J Antibiot; 1983 Oct; 36(10):2711-4. PubMed ID: 6325740
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study of cefotiam in pediatric field (author's transl)].
Aoyama R; Nagata K; Izumi Y; Kuronuma T; Asuka N
Jpn J Antibiot; 1981 May; 34(5):678-81. PubMed ID: 6270408
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of cefotiam in internal medicine, with special reference to infectious disease associated with hematological disorders (author's transl)].
Uchida T; Matsuda S; Tanaka T; Muroi S; Kimura H; Satoh T; Yui T; Satoh S; Fujino A; Mita M; Yamada Z; Kariyone S; Yoshida H; Kikuta T; Miura N; Itoh K; Ikeda K; Nemoto T; Hiraguri M; Sanbe M; Takezawa M; Nakamura Y; Satoh Y; Funayama S; Igarashi T; Ogiu A; Maseki N; Komatsu M
Jpn J Antibiot; 1981 Aug; 34(8):1148-57. PubMed ID: 6275142
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies of cefotiam in otorhinolaryngologic infections].
Sato F; Tachibana M; Saito H; Mizukoshi O; Nishimura T; Saito A; Nakamura A; Okawa K; Takenouchi S; Yanohara K
Jpn J Antibiot; 1983 Oct; 36(10):2688-92. PubMed ID: 6325738
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of cefoxitin and cephalothin: an overview.
Neu HC
Rev Infect Dis; 1979; 1(1):144-51. PubMed ID: 400931
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with cefotiam (author's transl)].
Kanai A; Mori M
Jpn J Antibiot; 1981 May; 34(5):686-9. PubMed ID: 6270410
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effect of cefotiam on otorhinolaryngologic infections].
Nakashima T; Makishima K; Toriya Y; Murata Y; Watanabe H; Kannae S
Jpn J Antibiot; 1983 Oct; 36(10):2733-41. PubMed ID: 6325744
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial potency of cefotiam based on the clinical effect, MIC and decrement of organisms in the sputum].
Kawagoe M; Narushima K; Kitani A; Shibuya T; Hara M; Hosono K; Shitara M
Jpn J Antibiot; 1983 Aug; 36(8):2053-7. PubMed ID: 6317912
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of a cephalosporin derivative, cefotiam, on otorhinolaryngologic infections].
Baba S; Wada K; Hatano T; Kinoshita H; Sugimori H; Sasaki T; Miyano K; Maruyama H; Takimoto I; Inafuku S
Jpn J Antibiot; 1983 Oct; 36(10):2693-710. PubMed ID: 6325739
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of cefotiam in internal medicine].
Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Aizawa M; Nara H; Yanagiya S; Fukushi K; Ohmi T; Okamoto K; Komatsu Y; Haneda Y; Tanabe K; Segawa M; Yamagata A; Kawatsu S
Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697
[TBL] [Abstract][Full Text] [Related]
17. [A clinical study on high dosages of cefotiam in serious infections associated with hematological disorders].
Kaku K; Inoue M; Inoue Y; Ookubo M; Matsutani A; Fujii Y; Kaneko T
Jpn J Antibiot; 1982 May; 35(5):1172-6. PubMed ID: 6290702
[No Abstract] [Full Text] [Related]
18. Clinical evaluation of cefotiam and cefamandole in respiratory tract infections.
Beumer HM; Olislagers WP; Kahn M; van Hamersveld JD
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):105-8. PubMed ID: 3886564
[TBL] [Abstract][Full Text] [Related]
19. [Clinical laboratory approach for determination of effective dose of cefotiam. Observation from disc susceptibility test and MICs].
Uete T; Tsuzaki Y; Furukawa S; Matsuo K
Jpn J Antibiot; 1982 Jun; 35(6):1441-61. PubMed ID: 6290707
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and clinical studies of cefotiam in digestive diseases].
Kanoh H; Sakakibara K; Nukuta N; Mizokami M; Ninomiya N; Katoh T; Tokuda Y; Izuchi K; Yamashita Y; Kawamura T
Jpn J Antibiot; 1984 Feb; 37(2):209-18. PubMed ID: 6330390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
